← Scroll for more →
Financial Statements — ARGX
Balance Sheet
(in billions USD)| Metric | Q2 2025 | Q2 2024 | Q2 2023 | Q2 2022 | Q2 2021 |
|---|---|---|---|---|---|
| Cash & Equivalents | 0.37 | 1.44 | 1.11 | 1.37 | 1.58 |
| Inventory | 0.34 | 0.33 | 0.20 | 0.14 | 0.06 |
| Total Current Assets | 5.83 | 4.26 | 2.69 | 2.93 | 2.86 |
| Total Non-current Assets | 1.35 | 0.53 | 0.50 | 0.32 | 0.35 |
| Total Assets | 7.18 | 4.80 | 3.19 | 3.25 | 3.21 |
| Total Current Liabilities | 1.04 | 0.50 | 0.32 | 0.26 | 0.24 |
| Total Non-current Liabilities | 0.04 | 0.03 | 0.02 | 0.01 | 0.02 |
| Total Liabilities | 1.08 | 0.53 | 0.34 | 0.28 | 0.26 |
| Retained Earnings | (1.16) | (2.44) | (2.23) | (1.84) | (0.93) |
| Total Stockholder Equity | 6.10 | 4.26 | 2.86 | 2.97 | 2.95 |
← Scroll for more columns →
Income Statement
(in billions USD) (except per-share rows)| Metric | Q2 2025 | Q2 2024 | Q2 2023 | Q2 2022 | Q2 2021 |
|---|---|---|---|---|---|
| Total Revenue | -- | -- | -- | 0.10 | 0.47 |
| Research & Development | 0.64 | 0.45 | 0.36 | 0.28 | 0.27 |
| Selling, General & Admin | 0.60 | 0.49 | 0.31 | 0.23 | 0.13 |
| Total Operating Expenses | 1.43 | 1.04 | 0.72 | 0.51 | 0.40 |
| Operating Income | 0.34 | (0.14) | (0.21) | (0.40) | 0.10 |
| Pretax Income | 0.49 | (0.09) | (0.16) | (0.45) | 0.08 |
| Tax Provision | 0.07 | (0.06) | (0.04) | (0.01) | 0.01 |
| Net Income | 0.41 | (0.03) | (0.12) | (0.44) | 0.06 |
| Basic EPS | 6.80 | (0.55) | (2.21) | (8.16) | 1.25 |
| Diluted EPS | 6.32 | (0.55) | (2.21) | (8.16) | 1.17 |
← Scroll for more columns →
Cash Flow Statement
(in billions USD)| Metric | Q2 2025 | Q2 2024 | Q2 2023 | Q2 2022 | Q2 2021 |
|---|---|---|---|---|---|
| Operating Cash Flow | 0.36 | (0.12) | (0.29) | (0.49) | (0.23) |
| Investing Cash Flow | 0.06 | (0.51) | 0.53 | (0.23) | (0.49) |
| Financing Cash Flow | 0.07 | 0.04 | 0.06 | 0.81 | 1.10 |
← Scroll for more columns →